期刊文献+

临床感染铜绿假单胞菌的分布及耐药性分析 被引量:3

Distribution and changes of drug resistance of pseudomonas aeruginosa in hospital infections
原文传递
导出
摘要 目的分析铜绿假单胞菌的临床分布及耐药谱的变迁,为临床合理选用抗菌药物提供依据。方法应用珠海黑马细菌鉴定药敏系统鉴定细菌和做体外药敏试验,统计分析我院2008年10月至2010年9月铜绿假单胞菌的分布和耐药情况。结果342株铜绿假单胞菌主要分布在重症监护病房和神经外科,来自痰标本的有279株(占81.6%),对抗生素的耐药性也较严重。结论铜绿假单胞茵是临床感染的主要病原菌之一,要加强对铜绿假单胞菌的耐药性检测并合理使用抗生素。 Objective To evaluate the distribution and antibiotics resistance of Pseudomonas aeruginosa(PA) in hospital infections and to provide evidences for clinic to select antimicrobial agents rationally. Methods The distribution and the ratio of antibiotics resistance in 342 species of PA isolated from clinical samples in our hospita since October 2008 to September 2010 was analyzed by WHONET 5.4 software. Results Three hundred and forty - two species of PA mainly distributed in ICU and neurosurgery. Among 342 species of PA, the resistance to antibiotics in 279 species from sputum specimens was the strongest. Conclusions PA is one of the main pathogenic bacteria in clinical infection. It is important to detect antibiotics resistance of PA in hospital infections and use antibiotics rationaly.
作者 孙俊
出处 《中国实用医刊》 2011年第13期50-51,共2页 Chinese Journal of Practical Medicine
关键词 铜绿假单胞菌 分布 耐药性 Pseudomonas aeruginosa Distribution Drug resistance
  • 相关文献

同被引文献36

  • 1周杰,于志军.铜绿假单胞菌感染的耐药分析[J].中国医师进修杂志,2007,30(3):28-29. 被引量:3
  • 2Berges L, Rodfiguez-Villalobos H, Deplano A, et al. Prospective evaluation of imipenem/EDTA combined disc and Etest for detection of metallo-beta-lactamase producing Pseudomonas aeruginosa. J Antimiemb Chemother,2007,59(4) :812-813.
  • 3Poirel L, Naas T, Nicolas D, et al. Characterization of VIM-2, a earbapenem-hydrolyzing metallo-beta-laeta-mase and its plasmid and integron-bome gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother, 2000,44 ( 4 ) : 891-897.
  • 4Senda K, Arakawa Y, Ichiyama S, et al. PCR detection of metallobeta · lactanmse gene(blMMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbial, 1996,34 ( 12 ) : 2909 -2913.
  • 5Dumas JL, van Delden C, Perron K, et al. Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR. FEMA Microbial Lett, 2006,254 ( 2 ) : 217- 225.
  • 6Mlynarczyk G, Sawicka-Grzelak A, Szymanek K, et al. Resistance to carbapenems among Pseudomonas aeruginosa isolatedfrom patients of transplant wards. Transplant Proc, 2009,41 ( 8 ) : 3258- 3260.
  • 7Kohler T, Michea-Hamzehpour M, Epp SF, et al. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of oprD and efflux systems. Antimicrob Agents Chemother, 1999, 43 ( 2 ) :424-427.
  • 8Morita Y,Kimura N,Mima T,et al. Roles of MexXY-and MexABmuhidrug efflux pumps in intrinsic multidrug resistance of Pseudomonas aeruginosa PAO1. J Gen Appl Microbiol,2001,47 ( 1 ) : 27 -32.
  • 9Vogne C, Aires JR, Bailly C, et al. Role of the Multidrug Efflux System MexXY in the Emergence of Moderate Resistance to Aminoglycosides among Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis. Antimicrob Agents Chemother, 2004, 48 (5) : 1676-1680.
  • 10Furukawa S, Kuchma SL, 0 "Toole GA. Keeping their options open : acute versus persistent infections. J Bacteriol, 2006, 188 (4) :1211-1217.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部